Cryosite Ltd (AU:CTE) — Market Cap & Net Worth
Market Cap & Net Worth: Cryosite Ltd (CTE)
Cryosite Ltd (AU:CTE) has a market capitalization of $36.95 Million (AU$52.23 Million) as of May 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #22967 globally and #876 in its home market, demonstrating a 1.90% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cryosite Ltd's stock price AU$1.07 by its total outstanding shares 48809563 (48.81 Million). Analyse Cryosite Ltd (CTE) cash conversion ratio to see how efficiently the company converts income to cash.
Cryosite Ltd Market Cap History: 2015 to 2026
Cryosite Ltd's market capitalization history from 2015 to 2026. Data shows growth from $6.50 Million to $36.95 Million (15.21% CAGR).
Cryosite Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cryosite Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.45x
Cryosite Ltd's market cap is 2.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
18.33x
Cryosite Ltd's market cap is 18.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.09 Million | $10.04 Million | $302.47K | 0.51x | 16.82x |
| 2017 | $3.73 Million | $5.81 Million | -$142.11K | 0.64x | N/A |
| 2018 | $1.34 Million | $5.86 Million | -$244.70K | 0.23x | N/A |
| 2019 | $1.58 Million | $7.91 Million | -$565.16K | 0.20x | N/A |
| 2020 | $11.79 Million | $8.92 Million | $1.48 Million | 1.32x | 7.97x |
| 2021 | $13.88 Million | $10.02 Million | $652.57K | 1.39x | 21.27x |
| 2022 | $22.08 Million | $11.76 Million | $1.36 Million | 1.88x | 16.19x |
| 2023 | $18.72 Million | $11.94 Million | $1.41 Million | 1.57x | 13.29x |
| 2024 | $29.36 Million | $12.61 Million | $1.84 Million | 2.33x | 15.95x |
| 2025 | $34.54 Million | $14.12 Million | $1.88 Million | 2.45x | 18.33x |
Competitor Companies of CTE by Market Capitalization
Companies near Cryosite Ltd in the global market cap rankings as of May 6, 2026.
Key companies related to Cryosite Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #125 globally with a market cap of $175.37 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.35 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #586 globally with a market cap of $44.95 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #644 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Thermo Fisher Scientific Inc | NYSE:TMO | $175.37 Billion | $466.76 |
| #189 | Danaher Corporation | NYSE:DHR | $123.35 Billion | $174.63 |
| #586 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.95 Billion | $562.97 |
| #644 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Cryosite Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Cryosite Ltd's market cap moved from $6.50 Million to $ 36.95 Million, with a yearly change of 15.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$36.95 Million | +7.00% |
| 2025 | AU$34.54 Million | +17.65% |
| 2024 | AU$29.36 Million | +56.80% |
| 2023 | AU$18.72 Million | -15.19% |
| 2022 | AU$22.08 Million | +59.00% |
| 2021 | AU$13.88 Million | +17.72% |
| 2020 | AU$11.79 Million | +645.63% |
| 2019 | AU$1.58 Million | +17.74% |
| 2018 | AU$1.34 Million | -64.01% |
| 2017 | AU$3.73 Million | -26.61% |
| 2016 | AU$5.09 Million | -21.73% |
| 2015 | AU$6.50 Million | -- |
End of Day Market Cap According to Different Sources
On May 6th, 2026 the market cap of Cryosite Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $36.95 Million USD |
| MoneyControl | $36.95 Million USD |
| MarketWatch | $36.95 Million USD |
| marketcap.company | $36.95 Million USD |
| Reuters | $36.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cryosite Ltd
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial … Read more